Last reviewed · How we verify
Standard Antibiotic Treatment
Standard antibiotic treatment works by inhibiting bacterial protein synthesis, cell wall formation, or nucleic acid replication to kill or stop the growth of susceptible bacteria.
Standard antibiotic treatment works by inhibiting bacterial protein synthesis, cell wall formation, or nucleic acid replication to kill or stop the growth of susceptible bacteria. Used for Bacterial infections (specific indication depends on antibiotic class and spectrum).
At a glance
| Generic name | Standard Antibiotic Treatment |
|---|---|
| Sponsor | Dr Hamail Khanum |
| Drug class | Antibiotic (broad class) |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
Antibiotics are a broad class of antimicrobial agents that target essential bacterial processes. Depending on the specific antibiotic (e.g., beta-lactams, aminoglycosides, fluoroquinolones, macrolides), they may disrupt peptidoglycan synthesis in the cell wall, inhibit ribosomal protein synthesis, interfere with DNA/RNA replication, or disrupt metabolic pathways unique to bacteria, thereby eliminating the infection.
Approved indications
- Bacterial infections (specific indication depends on antibiotic class and spectrum)
Common side effects
- Gastrointestinal upset (nausea, diarrhea, vomiting)
- Allergic reactions (rash, urticaria)
- Photosensitivity (with certain classes)
- Tendinopathy (with fluoroquinolones)
Key clinical trials
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection (PHASE1, PHASE2)
- Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
- Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis (NA)
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
- Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections (PHASE2)
- MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia (PHASE1)
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) (PHASE2)
- Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard Antibiotic Treatment CI brief — competitive landscape report
- Standard Antibiotic Treatment updates RSS · CI watch RSS
- Dr Hamail Khanum portfolio CI